Skip to main content
SpringerLink
Log in

Non-Platinum Antitumor Compounds

  • Chapter
Metallopharmaceuticals I

Part of the book series: Topics in Biological Inorganic Chemistry ((TBIC,volume 1))

Abstract

Non-platinum antitumor compounds have gained increasing interest during the last decade. A variety of antitumor active agents, from early transition to main-group metal or metalloid compounds, has been found and evaluated. Due to their different chemical characteristics, the mode of action and spectrum of activity of these compounds differ from each other. Antitumor activity in vitro is known for many compounds. Some compounds, like the ruthenium complexes, also exhibit promising in vivo activity. Two early transition metal complexes show interesting activity especially in experimental colon tumor models and are under evaluation in clinical trials: titanocene dichloride and budotitane. The two germanium complexes spirogermanium and germanium-132 have been evaluated but, despite their moderate toxicity, no encouraging results have been obtained. Gallium nitrate and gallium chloride are active against lymphomas and bladder cancer, and show a positive effect on hypocalcaemias caused by tumors. They have undergone a number of clinical trials and are being investigated in promising combination regimens. Arsenic trioxide was found to be active against a rare blood cancer in clinical studies in China.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adamson RH, Canellos GP, Sieber SM (1985) Cancer Chemother Rep 59: 599

    Google Scholar 

  2. Hayes RL, Nelson B, Swartzendruber DC, Carlton JE, Byrd BL (1970) Science 167: 289

    PubMed  CAS  Google Scholar 

  3. Larson SM, Rasey JS, Allen DR, Nelson NJ, Grunbaum Z, Harp GD, Williams DL (1980) J Natl Cancer Inst 64: 41

    PubMed  CAS  Google Scholar 

  4. Chitambar CR, Zivkovic Z (1987) Cancer Res 47: 3929

    PubMed  CAS  Google Scholar 

  5. Chitambar CR, Sax D (1992) Blood 80: 505

    PubMed  CAS  Google Scholar 

  6. Hegge FN, Mahler DJ, Larson SM (1977) J Nucl Med 18: 937

    PubMed  CAS  Google Scholar 

  7. Chitambar CR, Werely JP (1997) J Biol Chem 272: 12151

    PubMed  CAS  Google Scholar 

  8. Chitambar CR, Narasimhan J, Guy J, Sem DS, O’Brien WJ (1991) Cancer Res 51: 6199

    PubMed  CAS  Google Scholar 

  9. Foster BJ, Clagett-Carr K, Hoth D, Leyland-Jones B (1986) Cancer Treat Rep 70: 1311

    PubMed  CAS  Google Scholar 

  10. Crawford ED, Saiers JH, Baker LH, Costanzi JH, Bukowski RM (1991) Urology 38: 355

    PubMed  CAS  Google Scholar 

  11. Seidman AD, Scher HI, Heinemann MH et al. (1991) Cancer 68: 2561

    PubMed  CAS  Google Scholar 

  12. Warrell RP Jr, Coonley CJ, Straus DJ, Young CW (1983) Cancer 51: 1982

    PubMed  Google Scholar 

  13. Warrell RP Jr, Bockman RS, Coonley CJ, Isaacs M, Staszewski H (1984) J Clin Invest 73: 1487

    PubMed  CAS  Google Scholar 

  14. Jabboury K, Frye D, Holmes FA, Fraschini G, Hortobagyi G (1989) Invest New Drugs 7: 225

    PubMed  CAS  Google Scholar 

  15. Scher HJ, Curley T, Geller N, Dershaw D, Chan E, Nisselbaum J, Alcock N, Hollander P, Yagoda A (1987) Cancer Treatment Rep 71: 887

    CAS  Google Scholar 

  16. Warrell RP, Israel R, Frisone M, Snyder T, Gaynor JJ et al. (1988) Ann Internal Medicine 108: 669

    Google Scholar 

  17. Warrell RP, Murphy WK, Schulman P, O’Dwyer PJ, Heller G (1991) J Clin Oncol 19: 1467

    Google Scholar 

  18. Collery P, Morel M (1990) Oral administration of gallium in conjunction with platinum in lung cancer treatment. In: Collery P, Poirier LA et al. (eds) Metal ions in biology and medicine. John Libbey Eurotext, Paris, p 437

    Google Scholar 

  19. Einhorn LH, Roth BS, Ansari R et al. (1994) J Clin Oncol 12: 2271

    PubMed  CAS  Google Scholar 

  20. Dreicer R, Propert KJ, Roth BJ, Einhorn LH, Loehrer PJ (1997) Cancer 79: 110

    PubMed  CAS  Google Scholar 

  21. Dreicer R, Lallas TA, Joyce JK, Anderson B, Sorosky JI, Buller RE (1998) Am J Clin On-col 21: 287

    CAS  Google Scholar 

  22. McCaffrey JA, Hilton S, Mazumdar M, Sadan S, Heineman M, Hirsch J, Kelly WK, Scher HI, Bajorin DF (1997) 15: 2449

    CAS  Google Scholar 

  23. Chitambar CR, Zahir SA, Ritch PS, Anderson T (1997) Am J Clin Oncol 20: 173

    PubMed  CAS  Google Scholar 

  24. Lundberg JL, Chitambar CR (1990) Cancer Res 50: 6466

    PubMed  CAS  Google Scholar 

  25. Chitambar CR, Werely JP, Haq RU (1994) Cancer Res 54: 3224

    PubMed  CAS  Google Scholar 

  26. Hata Y, Sandler A, Loehrer PJ, Sledge GW Jr, Weber G (1994) Oncol Res 6: 19

    PubMed  CAS  Google Scholar 

  27. Collery P, Millart H, Pechery C, Kratz F, Keppler BK (1992) New gallium complexes for a cisplatin combination therapy. In: Anastassopoulou J, Collery P, Etienne JC, Theophanides T (eds) Metal ions in biology and medicine, Vol 2. John Libbey Eurotext, Paris, p 173

    Google Scholar 

  28. Collery P, Domingo JL, Keppler BK (1996) Anticancer Res 16: 687

    PubMed  CAS  Google Scholar 

  29. Gey DC, Schilling T, Keppler BK, Thiel M, Schmidt-Gayk H, Raue F, Ziegler R (1997) Exp Clin Endocrinol Diabetes 105: 6

    Google Scholar 

  30. Winter B, Schilling T, Gey DC, Keppler BK, Ziegler R (1998) Exp Clin Endocrinol Diabetes 106: 83

    Google Scholar 

  31. Rice LM, Slavik M, Schein P (1977) Clinical brochure: spirogermanium (NSC-192965). National Cancer Institute, Bethesda, MD

    Google Scholar 

  32. Hill BT, Whatley SA, Bellamy AS, Jenkins LY, Whelan RDH (1982) Cancer Res 42: 2852

    PubMed  CAS  Google Scholar 

  33. Whelan RD, Hill BT (1982) Br J Cancer 45: 639

    Google Scholar 

  34. Goodwin JW, Kopecky K, Slavik M, Tranum BL, Balcerzak SP, Fletcher WS, Constanzi JJ (1987) Cancer Treatment Rep 71: 985

    CAS  Google Scholar 

  35. Slavik M, Elias L, Mrema J, Saiers JH (1982) Drugs Exptl Clin Res 8: 379

    CAS  Google Scholar 

  36. Slavik M, Blanc O, Davis J (1983) Invest New Drugs 1: 225

    PubMed  CAS  Google Scholar 

  37. Ettinger DS, Finkelstein DM, Abeloff MD, Chang YC, Smith TJ, Oken MM, Ruckdeschel JC (1990) Invest New Drugs 8: 183

    PubMed  CAS  Google Scholar 

  38. McMaster ML, Greco FA, Johnson DH, Hainsworth JD (1990) Invest New Drugs 8: 87

    PubMed  CAS  Google Scholar 

  39. Sato H, Iwaguchi A (1979) lap J Cancer Chemother 6:79

    Google Scholar 

  40. Kumano N, Ishikawa T, Koinamura S, Kikumoto T, Suzuki S, Nakai Y, Konno K (1985) Tohuku J Exp Med 146: 97

    CAS  Google Scholar 

  41. Suzuki F, Pollard RB (1984) J Interferon Res 4: 223

    PubMed  CAS  Google Scholar 

  42. Ikemoto K, Kobayashi M, Fukumoto T, Morimatsu M, Pollard RB, Suzuki F (1996) Experientia 52: 159

    PubMed  CAS  Google Scholar 

  43. Nakada Y, Kosaka T, Kuwabara M, Tanaka S, Sato K, Koide F (1993) J Vet Med Sci 55: 795

    PubMed  CAS  Google Scholar 

  44. Hopkins SJ (1980) Drugs of the Future 5: 545

    Google Scholar 

  45. Kumano N, Nakai Y, Ishikawa T, Koinamura S, Suzuki S, Kikumoto T, and Konno (1980) In: Nelson JD, Grassi CD (eds) Current chemotherapy and infectious disease, Proc 11th Int Congr Chemother, American Society for Microbiology, Washington, p 1525

    Google Scholar 

  46. Miyao K, Onishi T, Asai K, Tomizawa S, Suzuki F (1980) In: Nelson JD, Grassi CD (eds) Current chemotherapy and infectious disease, Proc 1 lth Int Congr Chemother, American Society for Microbiology, Washington, p 1527

    Google Scholar 

  47. Sugiya Y, Sugita T Sakamaki S, Abo Y, Satoh H (1986) Oyo Yakuri 23: 93

    Google Scholar 

  48. Suzuki F, Brutkiewicz RR, Pollard RB (1985) Br J Cancer 757

    Google Scholar 

  49. Suzuki F, Brutkiewicz RR, and Pollard RB (1985) Anticancer Res 5: 479

    PubMed  CAS  Google Scholar 

  50. Tsutsui M, Kakimoto N, Axtell DD, Oikawa H, Asaki K (1976) J Am Chem Soc 98: 8287

    CAS  Google Scholar 

  51. Ward SG, Taylor RC (1988) Antitumor activity of the main-group elements: aluminum, gallium, indium, thallium, germanium, lead, antimony and bismuth. In: Gielen M (ed) Metal-based antitumor drugs. Freund Publishing House Ltd, London, p 1

    Google Scholar 

  52. Sato I, Yuan BD, Nishimura T, Tanaka N (1985) J Biol Resp Modif 4: 159

    CAS  Google Scholar 

  53. Köpf-Maier P, Janiak C, Schumann H (1988) J Cancer Res Clin Oncol 114: 502

    PubMed  Google Scholar 

  54. Crowe AJ (1993) Tin analogues of cisplatin. In: Keppler BK (ed) Metal complexes in cancer chemotherapy. VCH, Weinheim, p 369

    Google Scholar 

  55. Crowe AJ, Smith PJ, Atassi G (1980) Chem Biol Interact 32: 171

    PubMed  CAS  Google Scholar 

  56. Crowe AI, Smith PJ, Atassi G (1984) Inorg Chim Acta 93: 179

    CAS  Google Scholar 

  57. Crowe AJ, Smith PJ (1980) Chem Ind 200

    Google Scholar 

  58. Gielen M, loosen E, Mancilla T, Jurkschat K, Willem R, Roobol C, Bernheim J, Atassi G, Huber F, Hoffmann E, Preut H, Mahieu B (1987) Main Group Met Chem 10: 147

    CAS  Google Scholar 

  59. Willem R, Biesemans M, Boualam M, Delmotte A, El Khloufi A, Gielen M (1993) Appl Organomet Chem 7: 311

    CAS  Google Scholar 

  60. Gielen M (1994) Metal-Based Drugs 1: 213

    PubMed  CAS  Google Scholar 

  61. Gielen M, Biesemans M, El Khloufi A, Meunier-Piret J, Kayser F, Willem R (1993) J Fluorine Chem 64: 279

    CAS  Google Scholar 

  62. Gielen M, El Khloufi A, Biesemans M, Bouhdid A, de Vos D, Mahieu B (1994) Metal-Based Drugs 1: 305

    PubMed  CAS  Google Scholar 

  63. Crowe Al (1988) in: Gielen MF (ed) Metal-based anti-tumor drugs. Freund Publishing House, London, p 103

    Google Scholar 

  64. Crowe AJ, Smith PJ, Atassi G (1980) Chem Biol Interact 32: 171

    PubMed  CAS  Google Scholar 

  65. Ruisi G, Silvestri A, LoGiudice MT, Barbieri R, Lamartina L, Atassi G, Huber F, Gräatz K (1985) J Inorg Biochem 25: 229

    PubMed  CAS  Google Scholar 

  66. Tiekink ERT, Gielen M, Bouhdid A, Willem R, Bregadze VI, Ermanson LV, Glazum SA (1997) Metal-Based Drugs 4: 75

    PubMed  CAS  Google Scholar 

  67. Mervis J (1996) Science 273: 578

    PubMed  CAS  Google Scholar 

  68. Chen GQ, Zhu J, Zhang TD,et al. (1996) Blood 88: 1052

    PubMed  CAS  Google Scholar 

  69. Shao W, Fanelli M, Ferrara FF et al. (1998) J Natl Cancer Inst 90: 124

    PubMed  CAS  Google Scholar 

  70. Chen GQ, Shi XG, Zhang TD et al. (1997) Blood 89: 3345

    PubMed  CAS  Google Scholar 

  71. Shen ZX, Chen GQ, Zhang TD et al. (1997) Blood 89: 3354

    PubMed  CAS  Google Scholar 

  72. Gianni M, Koken MHM, Chelbi-Alix MK, Benoit G, Lanotte M, Chen Z, De The H (1998) Blood 91: 4300

    PubMed  CAS  Google Scholar 

  73. König A, Wrazel L, Warrel RP jr, Rivi R, Pandolfi PP, Jakubowski A, Gabrilove JL (1997) Blood 90: 562

    PubMed  Google Scholar 

  74. Rivi R, Calleja E, König A, Lai L, Gambacorti-Passerine C, Scheinberg D, Gabrilove JL, Warrell RP Jr, Pandolfi PP (1996) Blood 88: 68a

    Google Scholar 

  75. Soignet S, Rivi R, Tong WP, Gabrilove J, Scheinberg DA, Pandolfi PP, Warrell RP Jr (1997) Proc Am Soc Clin Oncol 16: 4a

    Google Scholar 

  76. Köpf-Maier P, Klapötke T (1988) Inorg Chim Acta 152: 49

    Google Scholar 

  77. Dittes U, Diemer R, Keppler BK (1995) J Cancer Res Clin Oncol 121: A50

    Google Scholar 

  78. Pfestorf S, Depenbrock H, Keppler BK, Hanauske AR (1996) In: Havemann K, Wolf M (eds) 22nd Deutscher Krebskongreß Abstract Volume. OmniMed, Hamburg, p 164

    Google Scholar 

  79. Kondo Y, Satoh M, Imura N, Akimoto M (1991) Cancer Chemother Pharmacol 29: 19

    PubMed  CAS  Google Scholar 

  80. Kondo Y, Satoh M, Imura N, Akimoto M (1992) Anticancer Res 12: 2303

    PubMed  CAS  Google Scholar 

  81. Silvestru C, Socaciu C, Bara A, Haiduc I (1990) Anticancer Res 10: 803

    PubMed  CAS  Google Scholar 

  82. Bara A, Socaciu C, Silvestru C, Haiduc I (1991) Anticancer Res 11: 803

    Google Scholar 

  83. Socaciu C, Bara A, Silvestru C, Haiduc I (1991) In Vivo 5: 425

    PubMed  CAS  Google Scholar 

  84. Keppler BK, Silvestru C, Haiduc I (1994) Metal-Based Drugs 1: 73

    PubMed  CAS  Google Scholar 

  85. Curley T, Scher H, Thaler H, Yeh S, O’Dell M, Kher U, Friedlander-Klar H, Larson S; Foley K, Portenoy R (1992) Proc Ann Meet Am Soc Clin Oncol 11: A672

    Google Scholar 

  86. de Klerk JM, van het Schip AD, Zonnenberg BA, van Dijk A, Quirijnen 1M, Blijham GH, van Rijk PP (1996) J Nucl Med 37: 244

    PubMed  Google Scholar 

  87. Juweid M, Sharkey RM, Swayne LC, Griffiths GL, Dunn R, Goldenberg DM (1998) J Nucl Med 39: 34

    PubMed  CAS  Google Scholar 

  88. Jakobs AI, Fer M, Su FM, Breitz H, Thompson J, Goodgold H, Cain J, Heaps J, Weiden P (1993) Obstet Gynecol 82: 586

    Google Scholar 

  89. Köpf H, Köpf-Maier P (1979) Angew Chem 91: 509

    Google Scholar 

  90. Köpf-Maier P, Köpf H (1979) Z Naturforsch 34b: 805

    Google Scholar 

  91. Köpf-Maier P, Leitner M, Köpf H (1980) J Inorg Nucl Chem 42: 1789

    Google Scholar 

  92. Köpf-Maier P, Leitner M, Voigtländer R, Köpf H (1979) Z Naturforsch 34c: 1174

    Google Scholar 

  93. Köpf-Maier P, Köpf H (1988) Struct Bond 70: 103

    Google Scholar 

  94. Köpf-Maier P (1989) Cancer Chemother Pharmacol 23: 225

    PubMed  Google Scholar 

  95. Köpf-Maier P, Klapötke T (1992) Cancer Chemother Pharmacol 29: 361

    PubMed  Google Scholar 

  96. Köpf-Maier P, Klapötke T (1992) J Cancer Res Clin Oncol 118: 216

    PubMed  Google Scholar 

  97. Köpf-Maier P, Neuse E, Klapötke T, Köpf H (1989) Cancer Chemother Pharmacol 24: 23

    PubMed  Google Scholar 

  98. Christodoulou C, Ferry D, Fyfe D, Young A, Doran J, Sass G, Eliopoulos A, Sheehan T, Kerr DJ (1997) Proc Ann Meet Am Assoc Cancer Res 38: A1495

    Google Scholar 

  99. Berdel WE, Schmoll HJ, Scheulen ME, Korfel A, Grundel O, Harstrick A, Knoche M, Fels LM, Bach F, Baumgart J, Sass G (1995) Proc Ann Meet Am Soc Clin Oncol 14: A1512

    Google Scholar 

  100. McLaughlin ML, Cronan JM, Schaller TR, Snelling RD (1990) J Am Chem Soc 112: 8949

    CAS  Google Scholar 

  101. Christodoulou C, Eliopoulos AG, Young LS, Hodgkins L, Ferry DR, Kerr DJ (1998) Br J Cancer 77: 2088

    PubMed  CAS  Google Scholar 

  102. Keppler BK, Berger MR, Heim ME (1990) Cancer Treat Rev 17: 261

    PubMed  CAS  Google Scholar 

  103. Keppler BK, Diez A, Seifried V (1985) Drug Res 35: 1832

    CAS  Google Scholar 

  104. Keppler BK, Friesen C, Moritz HG,Vongerichten H, Vogel E (1991) Struct Bond 78: 97

    CAS  Google Scholar 

  105. Bischoff H, Berger MR, Keppler BK, Schmähl D (1987) J Cancer Res Clin Oncol 113: 446

    PubMed  CAS  Google Scholar 

  106. Keppler BK, Heim ME (1988) Drugs of the Future 13: 637

    Google Scholar 

  107. Keppler BK, Friesen C,Vongerichten H, Vogel E (1993) Budotitane, a new tumor-inhibiting titanium compound. In: Keppler BK (ed) Metal complexes in cancer chemotherapy. VCH, Weinheim, p 187

    Google Scholar 

  108. Heim ME, Keppler BK (1987) J Cancer Res Clin Oncol 113: 46

    Google Scholar 

  109. Keppler BK, Bischoff H, Berger MR, Heim ME, Reznik G, Schmähl D (1988) Preclinical development and first clinical studies of budotitane. In: Nicolini M (ed) Proceedings of the 5th international symposium on platinum and metal coordination compounds in cancer chemotherapy. Martinus Nijhoff Publishing, Boston, p 684

    Google Scholar 

  110. Keppler BK, Heim ME, Flechtner H, Wingen F, Pool BL (1989) Drug Res 39: 706

    CAS  Google Scholar 

  111. Heim ME, Bischoff H, Keppler BK (1990) Clinical studies with budotitane. In: Collery P, Poirier LA, Manfait M, Etienne JC (eds) Metal ions in biology and medicine, John Libbey Eurotext, Paris, p 508

    Google Scholar 

  112. Müller U, Schilling T, Keppler BK, Heim ME, Burk K, Rastetter J, Hanauske AR (1994) J Cancer Res Clin Oncol 120: R13

    Google Scholar 

  113. Schilling T, Keppler BK, Heim ME, Niebch G, Dietzfelbinger H, Rastetter J, Hanauske AR (1996) Invest New Drugs 13: 327

    PubMed  CAS  Google Scholar 

  114. Cruz TF, Morgan A, Min W (1995) Proc Ann Meet Am Assoc Cancer Res 36: A2357

    Google Scholar 

  115. Sakurai H, Tamura H, Okatani K (1995) Biochem Biophys Res Commun 206: 133

    PubMed  CAS  Google Scholar 

  116. Evangelou A, Karkabounas S, Kalpouzos G, Malamas M, Liasko R, Stefanou D, Vlahos AT, Kabanos TA (1997) Cancer Lett 119: 221

    PubMed  CAS  Google Scholar 

  117. Köpf-Maier P, Köpf H, Neuse EW (1984) J Cancer Res Clin Oncol 108: 336

    PubMed  Google Scholar 

  118. Lehmann TE, Ming lj, Rosen ME, Que L Jr (1997) Biochemistry 36: 2807

    PubMed  CAS  Google Scholar 

  119. Sugiura Y, Guan LL (1993) Supramol Chem 1: 313

    CAS  Google Scholar 

  120. Duff RJ, de Vroom E, Geluk A, Hecht SM, van der Marel GA, van Boom JH (1993) J Am Chem Soc 115: 3350

    CAS  Google Scholar 

  121. Carter BJ, de Vroom E, Long EC, van der Marel GA, van Boom JH, Hecht SM (1990) Proc Natl Acad Sci USA 87: 9373

    PubMed  CAS  Google Scholar 

  122. Kikuchi H, Tetsuka T (1992) J Antibiot 45: 548

    PubMed  CAS  Google Scholar 

  123. Byrnes RW, Templin J, Sem D, Lyman S, Petering DH (1990) Cancer Res 50: 5275

    PubMed  CAS  Google Scholar 

  124. Guan LL, Kuwahara J, Sugira Y (1993) Biochemistry 32 6141

    PubMed  CAS  Google Scholar 

  125. Thian VN, Yang P, Wang HF, Feng YL, Liu SX, Huang JL Polyhedron (1996) 15: 2771

    Google Scholar 

  126. Tamura H, Fuijita H (1997) Chem Lett 711

    Google Scholar 

  127. Hall IH, Rajendran KG, West DX, Liberta AE (1993) Anti-Cancer Drugs 4: 231

    PubMed  CAS  Google Scholar 

  128. West DX, Liberta AE, Rajendran KG, Hall IH (1993) Anti-Cancer Drugs 4: 241

    PubMed  CAS  Google Scholar 

  129. Hall IH, Miller MC III, West DX (1997) Metal-Based Drugs 4: 89

    PubMed  CAS  Google Scholar 

  130. Hodnett EM, Moore CH, French FA (1971) J Med Chem 14: 1121

    PubMed  CAS  Google Scholar 

  131. Osinsky SP, Levitin IY, Bubnovskaya LN, Kormuta NA, Ganusevich II, Tsikalova MV, Vol’pin ME (1997) Med Biol Environ 25: 75

    CAS  Google Scholar 

  132. Jung M, Kerr DE, Senter PD (1997) Arch Pharm 330: 173

    CAS  Google Scholar 

  133. Anghileri LJ (1975) Z Krebsforschung 83: 213

    CAS  Google Scholar 

  134. Clarke MJ (1980) The potential of ruthenium in anticancer pharmaceuticals. In: Martell EA (ed) Inorganic chemistry in biology and medicine. American Chemical Society, Washington, p 157

    Google Scholar 

  135. Giraldi T, Sava G, Bertoli G, Mestroni G, Zassinovich G (1977) Cancer Res 37: 2662

    PubMed  CAS  Google Scholar 

  136. Sava G, Giraldi T, Mestroni G, Zassinovich G (1983) Chem Biol Interact 45: 1

    PubMed  CAS  Google Scholar 

  137. Sava G, Pacor S, Zorzet S, Alessio E, Mestroni G (1989) Pharmacol Res 21: 617

    PubMed  CAS  Google Scholar 

  138. Mestroni G, Alessio E, Calligaris M, Attia WM, Quadrifoglio F, Cauci S, Sava G, Zorzet S, Pacor S, Monti-Bragadin C, Tamaro M, Dolzani L (1989) Progr Clin Biochem 10: 73

    Google Scholar 

  139. Pacor S, Sava G, Ceschia V, Bregnant F, Mestroni G, Alessio E (1991) Chem Biol Interact 78: 223

    PubMed  CAS  Google Scholar 

  140. Sava G, Pacor S, Coluccia M, Mariggio M, Cocchietto M, Alessio E, Mestroni G (1994) Drug Invest 8: 150

    CAS  Google Scholar 

  141. Sava G, Pacor S, Mestroni G, Alessio E (1992) Clin Exp Metastasis 10: 273

    PubMed  CAS  Google Scholar 

  142. Sava G, Pacor S, Bergamo A, Cocchietto M, Mestroni G, Alessio E (1995) Chem Biol Interact 95: 109

    PubMed  CAS  Google Scholar 

  143. Bergamo A, Cocchietto M, Capozzi I, Mestroni G, Alessio E, Sava G (1996) Anticancer Drugs 7: 697

    PubMed  CAS  Google Scholar 

  144. Coluccia M, Sava G, Salerno G, Bergamo A, Pacor S, Mestroni G, Alessio E (1995) Metal-Based Drugs 2: 195

    PubMed  CAS  Google Scholar 

  145. Barton JK (1986) Science 233: 727

    PubMed  CAS  Google Scholar 

  146. Grover N, Welch TW, Fairley TA, Cory M, Thorp HH (1994) Inorg Chem 33: 3544

    CAS  Google Scholar 

  147. Gupta M, Grover N, Neyhart GA, Singh P, Thorp HH (1993) Inorg Chem 32: 310

    CAS  Google Scholar 

  148. Grover N, Gupta N, Thorp HH (1992) J Am Chem Soc 114: 3390

    CAS  Google Scholar 

  149. Novakova O, Kasparkova J,Vrana O, van Vliet PM, Reedijk J, Brabec V (1995) Biochemistry 34: 12369

    Google Scholar 

  150. Vilaplana R, Romero MA, Quiros M, Salas JM, Gonzalez-Vilchez F (1995) Metal-Based Drugs 2: 211

    PubMed  CAS  Google Scholar 

  151. Carballo M, Vilaplana R, Marquez G, Conde M, Bedoya FJ, Gonzalez-Vilchez F, Sobri-no F (1997) Biochem J 328: 559

    PubMed  CAS  Google Scholar 

  152. Keppler BK, Lipponer KG, Stenzel B, Kratz F (1993) New tumor-inhibiting ruthenium complexes. In: Keppler BK (ed) Metal complexes in cancer chemotherapy. VCH, Weinheim, p 187

    Google Scholar 

  153. Seelig M, Berger MR, Keppler BK, Schmähl D (1990) Efficacy of two ruthenium complexes against chemically induced autochthonous colorectal carcinoma in rats. In: Collery P, Poirier LA, Manfait M, Etienne JC (eds) Metal ions in biology and medicine. John Libbey Eurotext, Paris, p 476

    Google Scholar 

  154. Berger MR, Seelig MH, Galeano A (1993) Metal complexes with specific activity against colorectal tumors: evaluation of a tumor model close to the clinical situation. In: Keppler BK (ed) Metal complexes in cancer chemotherapy. VCH, Weinheim, p 187

    Google Scholar 

  155. Keppler BK, Berger MR, Heim ME (1990) Cancer Treatment Rev 17: 261

    CAS  Google Scholar 

  156. Berger MR, Garzon FT, Keppler BK, Schmähl D (1989) Anticancer Res 9: 761

    PubMed  CAS  Google Scholar 

  157. Seelig MH, Berger MR, Keppler BK (1992) J Cancer Res Clin Oncol 118: 195

    PubMed  CAS  Google Scholar 

  158. Galeano A, Berger MR, Keppler BK (1992) Arzneimittelforschung/Drug Research 42: 821

    CAS  Google Scholar 

  159. Kreuser ED, Keppler BK, Berdel WE, Piest A, Thiel E (1992) Semin Oncol 19: 73

    PubMed  CAS  Google Scholar 

  160. Depenbrock H, Schmelcher S, Peter R, Keppler BK, Weirich G, Block T, Rastetter J, Hanauske AR (1997) Eur J Cancer 33: 2404

    PubMed  CAS  Google Scholar 

  161. Depenbrock H, Aumüller K, Peter R, Keppler BK, Schweighart S, Block T, Rastetter J, Hanauske AR (1997) J Cancer Res Clin Oncol 121: A51

    Google Scholar 

  162. Pieper T, Hartmann M, Sommer M, Keppler BK (1997) J Cancer Res Clin Oncol 123: S35

    Google Scholar 

  163. Chatlas J, van Eldik R, Keppler BK (1995) Inorg Cim Acta 233: 59

    CAS  Google Scholar 

  164. Ni Dhubhghaill OM, Hagen WR, Keppler BK, Lipponer KG, Sadler P (1994) J Chem Soc Dalton Trans 3305

    Google Scholar 

  165. Anderson C, Beauchamp AL (1995) Can J Chem 73: 471

    CAS  Google Scholar 

  166. Clarke MJ (1989) Prog Clin Biochem Med 10: 25

    CAS  Google Scholar 

  167. Clarke MJ, Bitler S, Rennert D, Buchbinder M, Kelman AD (1980) J Inorg Biochem 12: 79

    PubMed  CAS  Google Scholar 

  168. Hartmann M, Lipponer KG, Keppler BK (1998) 267: 137

    CAS  Google Scholar 

  169. Clarke MJ, Jansen B, Marx KA, Kruger R (1986) Inorg Chim Acta 124: 13

    CAS  Google Scholar 

  170. Frasca D, Ciampa J, Emerson J, Umans RS, Clarke MJ (1996) Metal-Based Drugs 3: 197

    PubMed  CAS  Google Scholar 

  171. Srivastava SC, Mausner LF, Clarke MJ (1989) In: Progress in clinical biochemistry and medicine. Springer, Berlin Heidelberg New York, 10: 111

    Google Scholar 

  172. Messori L, Kratz F, Alessio E (1996) Metal-Based Drugs 3: 1

    PubMed  CAS  Google Scholar 

  173. Kratz F, Hartmann M, Keppler BK, Messori L (1994) J Biol Chem 269: 2581

    PubMed  CAS  Google Scholar 

  174. Smith CA, Sutherland-Smith AJ, Keppler BK, Kratz F, Baker EN (1996) J Bioinorg Chem 1: 424

    CAS  Google Scholar 

  175. Kratz F, Keppler BK, Hartmann M, Messori L, Berger MR (1996) Metal-Based Drugs 3: 15

    PubMed  CAS  Google Scholar 

  176. Erck A, Rainen L, Whilleyman J, Chang JM, Kimball AP, Bear J (1974) Proc Soc Exp Biol Med 145: 1278

    PubMed  CAS  Google Scholar 

  177. Pruchnik FP, Kluzewska G, Wilczock A, Mazurek U (1997) J Inorg Biochem 65: 25

    CAS  Google Scholar 

  178. Pruchnik F, Dus D (1996) J Inorg Chem 61: 55

    CAS  Google Scholar 

  179. Trynda L, Pruchnik F (1995) J Inorg Biochem 58: 69

    PubMed  CAS  Google Scholar 

  180. Trynda L, Pruchnik F (1997) J Inorg Biochem 66: 187

    Google Scholar 

  181. Dimitrov NV, Eastland GW (1977) In: International Congress on Chemotherapy Proceedings of the 10th Current Chemotherapy, p 1319

    Google Scholar 

  182. Eastland GW, Yang G, Thompson T (1983) Meth Find Exptl Clin Pharmacol 5: 435

    CAS  Google Scholar 

  183. Mestroni G, Alessio E, Sessanta o Santi A, Geremia S, Bergamo A, Sava G, Boccarelli A, Schettino A, Coluccia M (1998) Inorg Chim Acta 273: 62

    CAS  Google Scholar 

  184. Craciunescu DG, Scarcia V, Furlani A, Papaioannou A, Parrondo JE, Alonso MP (1991) In Vivo 5: 329

    PubMed  CAS  Google Scholar 

  185. Hohmann H, van Eldik R (1990) Inorg Chim Acta 174: 87

    CAS  Google Scholar 

  186. Hohmann H, Suvachittanont S, van Eldik R (1990) Inorg Chim Acta 177: 51

    CAS  Google Scholar 

  187. Gill DS (1984) Develop Oncol 17: 267

    CAS  Google Scholar 

  188. Higgins JD, Neely L, Fricker S (1993) J Inorg Biochem 49: 149

    PubMed  CAS  Google Scholar 

  189. Papageorgiou A, lakovidou Z, Mourelatos D, Miglou E, Boutis L, Kotsis A, Kovala-Demertzi D, Domapoulou A, West DX, Demertzis MA (1997) Anticancer Res 17: 247

    PubMed  CAS  Google Scholar 

  190. Tusek-Bozic L, Matijasic I, Bocelli G, Calestani G, Furlani A, Scarcia V, Papaioannou A (1991) J Chem Soc Dalton Trans 195

    Google Scholar 

  191. Elo H, Lumme P (1987) Inorg Chim Acta 136: 149

    CAS  Google Scholar 

  192. Elo H, Lumme P (1985) Cancer Treatment Rep 69: 1021

    CAS  Google Scholar 

  193. Lumme P, Elo H, Jänne J (1984) Inorg Chim Acta 92: 241

    CAS  Google Scholar 

  194. Lumme P, Elo H (1985) Inorg Chim Acta 107: L15

    CAS  Google Scholar 

  195. Scarcia V, Furlani A, Philloni G, Lorain B (1997) Inorg Chim Acta 254: 199

    CAS  Google Scholar 

  196. Adwanker MK, Wycliff C, Samuelson A (1997) Indian J Exp Biol 35: 810

    CAS  Google Scholar 

  197. Hall IH, Taylor K, Miller MC III, Dothan X, Khan MA, Bouet FM (1997) Anticancer Res 17: 2411

    PubMed  CAS  Google Scholar 

  198. Khanam JA, Bag SP, Sur B, Sur P (1997) Indian J Pharmacol 29: 157

    CAS  Google Scholar 

  199. Petering DH (1980) Carcinostatic copper complexes. In: Sigel H (ed) Metal ions in biological systems. Marcel Dekker, New York, p 197

    Google Scholar 

  200. Umezawa H, Takita T (1980) Struct Bonding 40: 73

    CAS  Google Scholar 

  201. West DX, Ingram JJ, Kozub NM, Bain GA, Liberta AE (1996) Transition Met Chem 21: 213

    CAS  Google Scholar 

  202. Oikawa T, Hirotani K, Ogasawara H, Katayama T, Ashinofuse H, Shimamura M, Iwaguchi T, Takamura 0 (1990) Chem Pharm Bull 38: 1790

    PubMed  CAS  Google Scholar 

  203. Brown SJ, Hudson SE, Stephan DW, Mascharak PK (1989) Inorg Chem 28: 468

    CAS  Google Scholar 

  204. Miller MC III, Sood A, Spielvogel BF, Hall IH (1998) Appl Organomet Chem 12: 87

    CAS  Google Scholar 

  205. Miller MC III, Sood A, Spielvogel BF, Hall IH (1998) Metal-Based Drugs 5: 1

    PubMed  CAS  Google Scholar 

  206. Geromichalos GD, Katsoulos GA, Hadjikostas CC, Kortsaris AH, Kyriakidis DA (1996) Anti-Cancer Drugs 7: 469

    PubMed  CAS  Google Scholar 

  207. Sutton BM, Franz RG (eds) (1983) Bioinorganic chemistry of gold coordination compounds. Smith Kline & French Laboratories, Philadelphia

    Google Scholar 

  208. Ni Dhubhghaill OM, Sadler PJ (1993) Gold complexes in cancer chemotherapy. In: Keppler BK (ed) Metal complexes in cancer chemotherapy. VCH, Weinheim, p 222

    Google Scholar 

  209. Lewis AJ, Walz DT (1982) Immunopharmacology of gold. In: Ellis GP, West GB (eds) Progr Medicinal Chem 19. Elsevier Biomedical Press, Lausanne

    Google Scholar 

  210. Berners-Price SJ, Girard GR, Hill DT, Sutton BM, Jarrett PS, Faucette LF, Johnson RK, Mirabelli CK, Christopher K, Sadler PJ (1990) J Med Chem 33: 1386

    PubMed  CAS  Google Scholar 

  211. Sadler PJ (1991) Adv Inorg Chem 36: 1

    CAS  Google Scholar 

  212. Shi JC, Chen LJ, Huang XY, Wu DX, Kang BS (1997) J Organomet Chem 535: 17

    CAS  Google Scholar 

  213. Garcia-Orad A, Arizti P, Sommer F, Silvestro L, Massiot P, Chevallier P, Gutierrez-Zorrilla JM, Colacio E, Martinez de Pancorbo M, Tapiero H (1993) Biomed Pharmacother 47: 363

    PubMed  CAS  Google Scholar 

  214. Berners-Price SJ, Mirabelli CK, Johnson RK, Mattern MR, McCabe FL, Faucette LF, Sung C-m, Mong S-M, Sadler PJ, Crooke ST (1986) Cancer Res 46: 5486

    PubMed  CAS  Google Scholar 

  215. Berners-Price SJ, Sadler PJ (1988) Structure and Bonding 70: 28

    Google Scholar 

  216. Calami P, Carotti S, Guerri A, Messori L, Mini E, Orioli P, Sperio GP (1997) J Inorg Biochem 66: 103

    Google Scholar 

  217. Cossu F, Matovic Z, Radanovic D, Ponticelli G (1994) Farmaco 49: 301

    PubMed  CAS  Google Scholar 

  218. Calamai P, Carotti S, Guerri A, Mazzei T, Messori L, Mini E, Orioli P, Speroni GP (1998) Anti-Cancer Drug Des 13: 67

    CAS  Google Scholar 

  219. Klenner T, Valenzuela Paz P, Amelung F, Winch H, Zahn H, Keppler BK, Blum H (1993) Platinum phosphonato complexes with particular activity against bone malignancies. In: Keppler BK (ed) Metal complexes in cancer chemotherapy. VCH, Weinheim, p 85

    Google Scholar 

  220. von Angerer E (1993) Platinum complexes with specific activity against hormone-dependent tumors. In: Keppler BK (ed) Metal complexes in cancer chemotherapy. VCH, Weinheim, p 73

    Google Scholar 

  221. Kratz F, Fichtner I, Beyer U et al. (1997) Eur J Cancer 33: S175

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Inorganic Chemistry, University of Vienna, Waehringerstrasse 42, A-1090, Vienna, Austria

    Thomas Pieper, Karl Borsky & Bernhard K. Keppler

Authors
  1. Thomas Pieper
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Karl Borsky
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bernhard K. Keppler
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Chemistry, Merkert Center, Boston College, 02167, Chestnut Hill, MA, USA

    Michael J. Clarke

  2. Department of Chemistry, University of Edinburgh, King’s Building, West Mains Road, EH 3JJ, Edinburgh, Scotland, GB

    Peter J. Sadler

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Pieper, T., Borsky, K., Keppler, B.K. (1999). Non-Platinum Antitumor Compounds. In: Clarke, M.J., Sadler, P.J. (eds) Metallopharmaceuticals I. Topics in Biological Inorganic Chemistry, vol 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-03815-4_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-03815-4_7

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-08440-9

  • Online ISBN: 978-3-662-03815-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation